Adaptability costs in immune escape variants of vesicular stomatitis virus (Q40487554)

21 September 2017

Adaptability costs in immune escape variants of vesicular stomatitis virus (English)

1 reference

evasion of host immune response

21 September 2017

1 reference

1 reference

Esteban Domingo Solans

4

1 reference

21 September 2017

5

John J Holland

0 references

author name string

Isabel S Novella

1

1 reference

PubMed ID

15567030

21 September 2017

Dorothy L Gilbertson

2

1 reference

PubMed ID

15567030

21 September 2017

Belen Borrego

3

1 reference

21 September 2017

1 January 2005

1 reference

21 September 2017

1 reference

21 September 2017

107

1 reference

21 September 2017

1

1 reference

21 September 2017

27-34

1 reference

Transcriptional control of the RNA-dependent RNA polymerase of vesicular stomatitis virus

21 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.06.007

Resistance of human immunodeficiency virus type 1 to protease inhibitors: selection of resistance mutations in the presence and absence of the drug.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.06.007

Gradual adaptation of HIV to human host populations: good or bad news?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.06.007

Positively charged amino acid substitutions in the e2 envelope glycoprotein are associated with the emergence of venezuelan equine encephalitis virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.06.007

Vaccine-induced escape mutant of hepatitis B virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.06.007

HIV population dynamics in vivo: implications for genetic variation, pathogenesis, and therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.06.007

Competitive fitness of nevirapine-resistant human immunodeficiency virus type 1 mutants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.06.007

The quasispecies (extremely heterogeneous) nature of viral RNA genome populations: biological relevance--a review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.06.007

Microbial genetics: Evolution experiments with microorganisms: the dynamics and genetic bases of adaptation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.06.007

Progressive reversion of human immunodeficiency virus type 1 resistance mutations in vivo after transmission of a multiply drug-resistant virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.06.007

Neutralization escape mutants of type A influenza virus are readily selected by antisera from mice immunized with whole virus: a possible mechanism for antigenic drift

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.06.007

The interaction of antibody with the major surface glycoprotein of vesicular stomatitis virus I. Analysis of neutralizing epitopes with monoclonal antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.06.007

The interaction of antibody with the major surface glycoprotein of vesicular stornatitis virus II. Monoclonal antibodies to nonneutralizing and cross-reactive epitopes of Indiana and New Jersey serotypes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.06.007

Identification of epitopes associated with different biological activities on the glycoprotein of vesicular stomatitis virus by use of monoclonal antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.06.007

A new immune escape mutant of hepatitis B virus with an Asp to Ala substitution in aa144 of the envelope major protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.06.007

Glycoprotein evolution of vesicular stomatitis virus New Jersey

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.06.007

Implications of antiretroviral resistance on viral fitness

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.06.007

Contributions of vesicular stomatitis virus to the understanding of RNA virus evolution

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.06.007

Exponential increases of RNA virus fitness during large population transmissions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.06.007

Insertions in the reverse transcriptase increase both drug resistance and viral fitness in a human immunodeficiency virus type 1 isolate harboring the multi-nucleoside reverse transcriptase inhibitor resistance 69 insertion complex mutation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.06.007

Full-length genome analysis of natural isolates of vesicular stomatitis virus (Indiana 1 serotype) from North, Central and South America

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.06.007

Respiratory syncytial virus genetic and antigenic diversity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.06.007

Mutations of respiratory syncytial virus attachment glycoprotein G associated with resistance to neutralization by primate polyclonal antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.06.007

Sequences of the major antibody binding epitopes of the Indiana serotype of vesicular stomatitis virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.06.007

Vesicular stomatitis new jersey virus glycoprotein gene sequence and neutralizing epitope stability in an enzootic focus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.06.007

Deduced structural model for animal rhabdovirus glycoproteins.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.06.007

Reduced positive selection in vector-borne RNA viruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.06.007

Characterization of T-helper epitopes of the glycoprotein of vesicular stomatitis virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.06.007

7 January 2021

Subclonal components of consensus fitness in an RNA virus clone

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.06.007

7 January 2021

Large-population passages of vesicular stomatitis virus in interferon-treated cells select variants of only limited resistance

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.06.007

7 January 2021

Neutralizing antibodies against hepatitis C virus and the emergence of neutralization escape mutant viruses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.06.007

7 January 2021

Resistance to neutralization by broadly reactive antibodies to the human immunodeficiency virus type 1 gp120 glycoprotein conferred by a gp41 amino acid change

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.06.007

7 January 2021

Monoclonal antibodies to the glycoprotein of vesicular stomatitis virus: comparative neutralizing activity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.06.007

7 January 2021

Resistance of human immunodeficiency virus type 1 to neutralization by natural antisera occurs through single amino acid substitutions that cause changes in antibody binding at multiple sites

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.06.007

7 January 2021

10.1016/J.VIRUSRES.2004.06.007

Identifiers

DOI

1 reference

21 September 2017

1 reference

PubMed ID

15567030